Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver

Erik R Wisner, Elaine Merisko-Liversidge, Kenneth Kellar, Richard W Katzberg, Piotr H. Karpinski, Eugenio G. Amparo, Christiana Drake, Stephen M Griffey, John M. Brock

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Rationale and Objectives.: We characterized the physical, biological, and imaging properties of a manganese (Mn) carbonate particle suspension, a contrast agent for hepatic magnetic resonance (MR) imaging. Methods.: Mn carbonate suspensions were produced by controlled precipitation and characterized using light microscopy, transmission electron microscopy, and in vitro relaxivity studies. Efficacy of the agent was studied in normal and tumor-bearing rats using T1-weighted MR imaging. Results.: Following intravenous injection of Mn carbonate particles at doses ranging from 10 to 100 μmol Mn/kg, peak hepatic contrast enhancement of approximately 35% occurred from about 125 min until the termination of the MR imaging studies that varied from 125 to 305 min. Lesion conspicuity was increased because of relative intensity differences between normal liver and tumor. Data also showed that Mn carbonate particle dissolved on delivery to the liver, allowing Mn to interact with intrahepatic macromolecular complexes to provide positive contrast enhancement. Conclusion.: Mn carbonate particles produce significant and sustained hepatic enhancement and should improve detection of small or isointense liver lesions.

Original languageEnglish (US)
Pages (from-to)140-147
Number of pages8
JournalAcademic Radiology
Volume2
Issue number2
DOIs
StatePublished - 1995

Fingerprint

Magnetic Resonance Imaging
Liver
Manganese
Suspensions
Macromolecular Substances
Transmission Electron Microscopy
Intravenous Injections
Contrast Media
manganese carbonate
Microscopy
Neoplasms
Light

Keywords

  • contrast media
  • liver
  • Magnetic resonance imaging
  • manganese carbonate nanoparticles

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Wisner, E. R., Merisko-Liversidge, E., Kellar, K., Katzberg, R. W., Karpinski, P. H., Amparo, E. G., ... Brock, J. M. (1995). Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver. Academic Radiology, 2(2), 140-147. https://doi.org/10.1016/S1076-6332(05)80149-7

Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver. / Wisner, Erik R; Merisko-Liversidge, Elaine; Kellar, Kenneth; Katzberg, Richard W; Karpinski, Piotr H.; Amparo, Eugenio G.; Drake, Christiana; Griffey, Stephen M; Brock, John M.

In: Academic Radiology, Vol. 2, No. 2, 1995, p. 140-147.

Research output: Contribution to journalArticle

Wisner, ER, Merisko-Liversidge, E, Kellar, K, Katzberg, RW, Karpinski, PH, Amparo, EG, Drake, C, Griffey, SM & Brock, JM 1995, 'Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver', Academic Radiology, vol. 2, no. 2, pp. 140-147. https://doi.org/10.1016/S1076-6332(05)80149-7
Wisner, Erik R ; Merisko-Liversidge, Elaine ; Kellar, Kenneth ; Katzberg, Richard W ; Karpinski, Piotr H. ; Amparo, Eugenio G. ; Drake, Christiana ; Griffey, Stephen M ; Brock, John M. / Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver. In: Academic Radiology. 1995 ; Vol. 2, No. 2. pp. 140-147.
@article{8eda471fdcef4ae2bb673d2f4a0128ed,
title = "Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver",
abstract = "Rationale and Objectives.: We characterized the physical, biological, and imaging properties of a manganese (Mn) carbonate particle suspension, a contrast agent for hepatic magnetic resonance (MR) imaging. Methods.: Mn carbonate suspensions were produced by controlled precipitation and characterized using light microscopy, transmission electron microscopy, and in vitro relaxivity studies. Efficacy of the agent was studied in normal and tumor-bearing rats using T1-weighted MR imaging. Results.: Following intravenous injection of Mn carbonate particles at doses ranging from 10 to 100 μmol Mn/kg, peak hepatic contrast enhancement of approximately 35{\%} occurred from about 125 min until the termination of the MR imaging studies that varied from 125 to 305 min. Lesion conspicuity was increased because of relative intensity differences between normal liver and tumor. Data also showed that Mn carbonate particle dissolved on delivery to the liver, allowing Mn to interact with intrahepatic macromolecular complexes to provide positive contrast enhancement. Conclusion.: Mn carbonate particles produce significant and sustained hepatic enhancement and should improve detection of small or isointense liver lesions.",
keywords = "contrast media, liver, Magnetic resonance imaging, manganese carbonate nanoparticles",
author = "Wisner, {Erik R} and Elaine Merisko-Liversidge and Kenneth Kellar and Katzberg, {Richard W} and Karpinski, {Piotr H.} and Amparo, {Eugenio G.} and Christiana Drake and Griffey, {Stephen M} and Brock, {John M.}",
year = "1995",
doi = "10.1016/S1076-6332(05)80149-7",
language = "English (US)",
volume = "2",
pages = "140--147",
journal = "Academic Radiology",
issn = "1076-6332",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver

AU - Wisner, Erik R

AU - Merisko-Liversidge, Elaine

AU - Kellar, Kenneth

AU - Katzberg, Richard W

AU - Karpinski, Piotr H.

AU - Amparo, Eugenio G.

AU - Drake, Christiana

AU - Griffey, Stephen M

AU - Brock, John M.

PY - 1995

Y1 - 1995

N2 - Rationale and Objectives.: We characterized the physical, biological, and imaging properties of a manganese (Mn) carbonate particle suspension, a contrast agent for hepatic magnetic resonance (MR) imaging. Methods.: Mn carbonate suspensions were produced by controlled precipitation and characterized using light microscopy, transmission electron microscopy, and in vitro relaxivity studies. Efficacy of the agent was studied in normal and tumor-bearing rats using T1-weighted MR imaging. Results.: Following intravenous injection of Mn carbonate particles at doses ranging from 10 to 100 μmol Mn/kg, peak hepatic contrast enhancement of approximately 35% occurred from about 125 min until the termination of the MR imaging studies that varied from 125 to 305 min. Lesion conspicuity was increased because of relative intensity differences between normal liver and tumor. Data also showed that Mn carbonate particle dissolved on delivery to the liver, allowing Mn to interact with intrahepatic macromolecular complexes to provide positive contrast enhancement. Conclusion.: Mn carbonate particles produce significant and sustained hepatic enhancement and should improve detection of small or isointense liver lesions.

AB - Rationale and Objectives.: We characterized the physical, biological, and imaging properties of a manganese (Mn) carbonate particle suspension, a contrast agent for hepatic magnetic resonance (MR) imaging. Methods.: Mn carbonate suspensions were produced by controlled precipitation and characterized using light microscopy, transmission electron microscopy, and in vitro relaxivity studies. Efficacy of the agent was studied in normal and tumor-bearing rats using T1-weighted MR imaging. Results.: Following intravenous injection of Mn carbonate particles at doses ranging from 10 to 100 μmol Mn/kg, peak hepatic contrast enhancement of approximately 35% occurred from about 125 min until the termination of the MR imaging studies that varied from 125 to 305 min. Lesion conspicuity was increased because of relative intensity differences between normal liver and tumor. Data also showed that Mn carbonate particle dissolved on delivery to the liver, allowing Mn to interact with intrahepatic macromolecular complexes to provide positive contrast enhancement. Conclusion.: Mn carbonate particles produce significant and sustained hepatic enhancement and should improve detection of small or isointense liver lesions.

KW - contrast media

KW - liver

KW - Magnetic resonance imaging

KW - manganese carbonate nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=0029240601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029240601&partnerID=8YFLogxK

U2 - 10.1016/S1076-6332(05)80149-7

DO - 10.1016/S1076-6332(05)80149-7

M3 - Article

VL - 2

SP - 140

EP - 147

JO - Academic Radiology

JF - Academic Radiology

SN - 1076-6332

IS - 2

ER -